IMDX 8-K: Secondary offering
Insight Molecular Diagnostics Inc.
Filed with the SEC on · accession 0001493152-26-053091
IMDX filed a 8-K (current report) with the SEC on Nov 18, 2026. Insight Molecular Diagnostics Inc. entered into an underwriting agreement with Lake Street Capital Markets for an underwritten public offering of 8,296,429 shares of common stock and pre-funded warrants to purchase up to 275,000 shares at $1.75 per share, expecting approximately $15.0 million in…
Summary of the filing
Insight Molecular Diagnostics Inc. entered into an underwriting agreement with Lake Street Capital Markets for an underwritten public offering of 8,296,429 shares of common stock and pre-funded warrants to purchase up to 275,000 shares at $1.75 per share, expecting approximately $15.0 million in gross proceeds for working capital and general corporate purposes.
Key details
✦ Ask GOAX AI about this filing — what it means for IMDX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMDX?
Click hereFrequently asked questions
What did IMDX file with the SEC on Nov 18, 2026?
IMDX filed a 8-K (Secondary offering). Insight Molecular Diagnostics Inc. entered into an underwriting agreement with Lake Street Capital Markets for an underwritten public offering of 8,296,429 shares of common stock and pre-funded warrants to purchase up to 275,000 shares at $1.75 per share, expecting approximately $15.0 million in gross proceeds for working capital and general corporate purposes.
What does a secondary offering mean for IMDX stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other IMDX SEC filings
- 10-Q · SEC filingNov 16, 2026
- 424B5 · Secondary offeringNov 16, 2026
- 8-K · SEC filingNov 16, 2026
- 8-K · Material agreementSep 21, 2026
- 8-K · Fda approvalAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · SEC filingJun 17, 2026
- 10-Q · SEC filingMay 13, 2026
- 8-K · SEC filingMay 13, 2026
- 8-K/A · Material agreementMay 13, 2026
Get alerts when IMDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days